Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs

Megan L Peach, Shaunna-L Beedie, Cindy H. Chau, Matthew K Collins, Suzana Markolovic, Weiming Luo, David Tweedie, Christian Steinebach, Nigel H Greig, Michael Gütschow, Neil Vargesson, Marc C. Nicklaus, William D Figg* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)
3 Downloads (Pure)


Due to its anti-angiogenic and anti-immunomodulatory activity, thalidomide continues to be of clinical interest despite its teratogenic actions, and efforts to synthesize safer, clinically-active thalidomide analogs are continually underway. In this study, a cohort of 27 chemically diverse thalidomide analogs was evaluated for anti-angiogenic activity in an ex-vivo rat aorta ring assay. The protein cereblon has been identified as the target for thalidomide and in silico pharmacophore analysis and molecular docking with a crystal structure of human cereblon were used to investigate the cereblon binding abilities of the thalidomide analogs. The results suggest that not all anti-angiogenic thalidomide analogs can bind cereblon, and multiple targets and mechanisms of action may be involved.
Original languageEnglish
Article number5683
Number of pages18
Issue number23
Publication statusPublished - 2 Dec 2020

Bibliographical note

Funding: This research was supported in part by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (ZIA SC006538); in part with Federal funds from the Frederick National Laboratory for Cancer Research, National Institutes of Health, under contract HHSN261200800001E; the Intramural
Research Program of the National Institute on Aging, National Institutes of Health; and a Wellcome Trust-NIH PhD Studentship to SB, WDF, and NV (Grant number 098252/Z/12/Z).
Acknowledgments: The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the US Government.


  • angiogenesis
  • thalidomide
  • SAR
  • cereblon
  • docking
  • structure-activity
  • relationships
  • structure–activity relationships


Dive into the research topics of 'Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs'. Together they form a unique fingerprint.

Cite this